Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled date : 2021 - 03 - 10 save search
Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Epoladerm(TM)
Published: 2021-03-10 (Crawled : 18:00) - biospace.com/
VRPX | $3.87 11.53% 10.34% 20K
|
|
| O: 2.2%
H: 2.74%
C: -2.15%
new drug drug
Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets
Published: 2021-03-10 (Crawled : 14:01) - prnewswire.com
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: 3.41%
H: 1.62%
C: -2.15%
drug discovery drug
Global Cancer Peptide Therapeutics Drug Market Size Clinical Trials Insight 2026
Published: 2021-03-10 (Crawled : 13:58) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 6.48%
H: 7.49%
C: 5.4%
trial drug cancer clinical trials
Global $112.14 Billion Oncology Drugs Markets, 2015-2020, 2020-2025F, 2030F
Published: 2021-03-10 (Crawled : 13:58) - prnewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.16%
H: 0.11%
C: -0.38%
drug
Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders
Published: 2021-03-10 (Crawled : 13:40) - biospace.com/
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: 3.41%
H: 1.62%
C: -2.15%
partnership biotech drug iot
Aligos Therapeutics Begins Dosing with STOPS™ Molecule Drug Candidate, ALG-010133, in First Cohort of Chronic Hepatitis B Patients in a Phase 1 Proof-of-Concept Study
Published: 2021-03-10 (Crawled : 13:05) - globenewswire.com
ALGS | $0.781 -0.76% -0.77% 240K
|
Health Technology
|
| O: 0.81%
H: 2.64%
C: -7.13%
hepatitis phase 1 drug phase 3 phase 2 chronic hepatitis b
Cocrystal Pharma Extends Drug Discovery Collaboration with HitGen and InterX
Published: 2021-03-10 (Crawled : 13:05) - globenewswire.com
COCP | $1.43 -1.39% 5.1K
|
Health Technology
|
| O: 2.6%
H: 0.63%
C: -6.33%
collaboration drug discovery drug pharma
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.